本页面由Tiger Trade Technology Pte. Ltd.提供服务

Lexeo Therapeutics

2.93
-0.1100-3.62%
成交量:15.37万
成交额:45.84万
市值:2.40亿
市盈率:-2.56
高:3.03
开:3.03
低:2.93
收:3.04
52周最高:10.99
52周最低:2.93
股本:8,204.63万
流通股本:5,122.95万
量比:1.37
换手率:0.30%
股息:- -
股息率:- -
每股收益(TTM):-1.1457
每股收益(LYR):-1.8634
净资产收益率:-46.76%
总资产收益率:-27.59%
市净率:1.02
市盈率(LYR):-1.57

数据加载中...

2025/02/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/02/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2025/01/13

重要事件披露

Form 8-K - Current report
2024/12/19

重要事件披露

Form 8-K - Current report
2024/12/17

SEC问询函

Form CORRESP - Correspondence
2024/12/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/14

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/13

重要事件披露

Form 8-K - Current report
2024/11/12

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/10/30

重要事件披露

Form 8-K - Current report
2024/10/09

重要事件披露

Form 8-K - Current report
2024/09/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/08/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/12

重要事件披露

Form 8-K - Current report
2024/08/09

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]